[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"content-doc-dcio8a90a70d":3},{"user":4,"document":8,"mainDocument":27,"columnUrl":29,"subscription":30,"footer":42,"text":80},{"isAuthenticated":5,"isAdmin":5,"displayName":6,"avatarUrl":6,"nid":6,"groupLevel":7},false,"",-10,{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":21,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"useContentVideo":5,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},"dcio8a90a70d","强生(JNJ)Q3盈利超预期并上调全年业绩指引！创新药业务放量-器械业务仍待改善","\u002Fdoc\u002Fdcio8a90a70d","col18178739ee","美股资讯","\u002Fcol\u002Fcol18178739ee","\u003Cp>\n\u003C\u002Fp>\u003Cp>\u003Cspan>美股投资网获悉，周二美股盘前，强生(JNJ)公布了好于预期的2026年第三季度业绩，并上调2026全年收入与盈利指引。财报显示，强生第三季度销售额同比增长5.9%至254亿美元，符合市场普遍预期。盈利方面，在GAAP口径下的净利润同比骤降95.9%至2.10亿美元，摊薄后每股收益仅为0.09美元(上年同期为2.12美元)，主因计入55.19亿美元滑石粉诉讼拟议解决方案相关一次性税前费用。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>剔除一次性项目与无形资产摊销等，调整后净利润为63.39亿美元;调整后每股收益为2.59美元，超出市场一致预期约2.53美元，但同比仍下降7.5%(上年同期为2.80美元);剔除汇率影响后的运营调整后每股收益为2.61美元。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>业务方面，创新药业务(Innovative Medicine)营收为167.57亿美元，同比增长7.7%。核心品种表现分化Darzalex营收同比增长15.4%至 42.39亿美元;自免药物Tremfya营收同比增长68.3%至23.96亿美元，超出市场预期的约21.9亿美元);精神科药物Carvykti营收同比增长35.5%至7.10亿美元;Stelara营收同比下滑54.4%至7.16亿美元，原因在于受仿制药冲击，但因剂量结构优化仍超出市场预期的约5.91亿美元。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>医疗器械业务(MedTech)营收为86.42亿美元，同比增长2.5%。首席财务官Joe Wolk表示，中东冲突、欧洲市场紧缩及中国定价压力对国际医疗设备销售形成“更明显的”拖累，Abiomed心室辅助泵业务仍受今年早前英国Impella研究影响。R&D投入同比增长26.7%至46.52亿美元，研发强度由去年同期的15.3%升至18.3%。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>指引方面， 强生上调2026全年报告销售收入指引中值，由约1,011亿美元升至1,012 亿美元(区间1,010–1,014亿美元)、调整后每股收益指引中值由11.04美元上调至11.10美元(区间11.05–11.15美元)，均高于市场一致预期。首席执行官Joaquin Duato表示，本季度“加速增长动能”延续，公司对“在本十年末实现两位数增长路径更清晰”，但未给出2027年具体数字。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>运营表现方面，第三季度内，OTTAVA软组织机器人手术系统获FDA上市许可，新药Imaaivy(nipocalimab)获FDA批准用于温抗体型自身免疫性溶血性贫血;公司完成对Firefly Bio的收购并与Sail Biomedicines达成in vivo CAR-T合作;Jennifer Taubert退休，Tom Cavanaugh出任创新药业务全球董事长。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>最专业的美股资讯,推荐美股大数据 \u003Ca href=\"https:\u002F\u002FStockwe.com\u002F\">https:\u002F\u002FStockwe.com\u002F\u003C\u002Fa>\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>如何识别美股市场异常波动？美国机构主力资金买卖情况，出货和吸筹，使用美股投资网VIP会员，2008年成立于美国硅谷，由前纽约证券交易所分析师Ken创立，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化模型，建立了一个股市数据库 \u003Ca href=\"https:\u002F\u002FStockWe.com\u002F\">https:\u002F\u002FStockWe.com\u002F\u003C\u002Fa> 每天处理千万级股票数据：捕捉期权大单，实时主力资金流向、机构持仓变化、川普突发新闻，精准交易信号第一时间发到您手机APP！\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003C\u002Fp>","https:\u002F\u002Fwww.tradesmax.com\u002Fimages\u002Fa_Stock\u002FJ\u002FJNJ\u002FJNJ2.jpg","2026-10-13T12:38:45","2026.10.13","2026\u002F10\u002F13",34520,[22],"JNJ","Article",0,"免费","success",{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":28,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"useContentVideo":5,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},[22],"\u002Fcol\u002Fstocknews",{"visible":5,"marketingHtml":31,"services":32,"recentDocuments":41},"\u003Cfigure class=\"image\">\u003Ca href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\" rel=\"noopener noreferrer\">\u003Cimg src=\"\u002Fimg\u002Fstockwewebfiles\u002Fweb-202408-stk\u002F1586109431mceclip0.jpg\">\u003C\u002Fa>\u003C\u002Ffigure>\u003Cdiv class=\"text-center\">\u003Ch2 class=\"card-title mx-auto\">\u003Cbr>\u003Ca rel=\"noopener noreferrer\" href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\">案例介绍：英伟达深度研究报告\u003C\u002Fa>\u003C\u002Fh2>\u003C\u002Fdiv>",[33,37],{"productId":34,"serviceName":35,"priceText":36},"prod_PPxdDdK87QaiLv","月付","$12.95美元",{"productId":38,"serviceName":39,"priceText":40},"prod_PPxeMs3bix1da5","年付","$149.00美元",[],{"links":43,"images":71,"summaryHtml":76,"aboutTitle":77,"aboutHtml":78,"copyrightHtml":79},[44,47,50,53,56,59,62,65,68],{"label":45,"url":46},"深度报告","\u002Fcol\u002FdepthReport",{"label":48,"url":49},"VIP会员","\u002Fvip",{"label":51,"url":52},"期权推荐","\u002FOption",{"label":54,"url":55},"低价暴涨股","\u002FPenny",{"label":57,"url":58},"AI智能体","\u002FAiAgent",{"label":60,"url":61},"常见问题","https:\u002F\u002Fstockwe.com\u002FFAQ",{"label":63,"url":64},"美股课程","\u002Fcol\u002Fvideos",{"label":66,"url":67},"免责声明","\u002Fdisclaimer",{"label":69,"url":70},"联系我们","\u002FContactUs",[72,73,74,75],"\u002Fimages\u002Ffooter\u002Ffooter-1-wechat.gif?v=20260930c","\u002Fimages\u002Ffooter\u002Ffooter-2-telegram.png?v=20260930c","\u002Fimages\u002Ffooter\u002Ffooter-3-whatsapp.png?v=20260930c","\u002Fimages\u002Ffooter\u002Ffooter-4-line.png?v=20260930c","邮箱: buy@TradesMax.com 美国电话 626-378-3637","公司介绍","\u003Cp class=\"MsoNormal\">美股大数据 \u003Ca href=\"https:\u002F\u002Fstockwe.com\" rel=\"noopener\">StockWe.com\u003C\u002Fa> 是一个美国领先的金融和美股信息大数据提供商，紧盯华尔街金融市场和行情，2008年成立于美国硅谷，创始人是前纽约证券交易所资深分析师Ken，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化交易模型，每天处理海量股票数据：挖掘潜力大牛股，捕捉期权异动大单，实时主力资金流向、机构持仓变化、川普突发新闻，美股买卖信号第一时间发到您手机APP。\u003C\u002Fp>","专业美股投资者都在这里",{"loading":81,"search":82,"searchPlaceholder":82,"hotContent":83,"draft":84,"noData":85,"searchNoData":86,"courseContent":87,"more":88,"buyNow":89,"subscribeNow":90,"encoding":91,"paidContent":92},"Loading...","搜索","热门内容","草稿","目前没有任何内容公布","当前检索内容没有数据","课程内容","更多","立即购买后观看","- 立即订阅 -","视频编码中...","付费内容"]